Day 39.
Enkrata now has a Monthly Reduction Report β shows how your relapse frequency, streak, and mood are trending compared to last month.
Not just "days clean" anymore. Real progress, tracked over time.
Tested it today. It works.
#buildinpublic#enkrata#nofap
@ardent__dev Maybe the tools get sharper, but risk-taking and ownership don't automate. AI can suggest, I'm still the one whose name is on it when it fails.
@thudarx I basically already do β Claude and Gemini handle most of my code and content while I sleep. The company runs, but the judgment calls still need me. AI executes well, it doesn't own risk.
@jack_startup Razorpay, easily β especially building from India. Local support, easier compliance, and honestly better docs for indie devs than most international options.
@mohabbuilds The "gentle nudge" language over alerts/reminders is a smart call β makes it feel supportive, not surveillance. The Circle view is clean too. Curious how you're handling it if someone doesn't want family tracking their doses at all β opt-out per medication or fully optional?
@mohabbuilds Exactly why I shipped a monthly trend report for Enkrata instead of just streak counters β a dip day doesn't erase the pattern, but a streak reset makes it feel like it does. What's the core problem you're solving with the medication app?
Day 39.
Enkrata now has a Monthly Reduction Report β shows how your relapse frequency, streak, and mood are trending compared to last month.
Not just "days clean" anymore. Real progress, tracked over time.
Tested it today. It works.
#buildinpublic#enkrata#nofap
@kayaravenya Execution, mostly. I use AI to build faster across three products at once β but the actual strategy (what to build, when to pivot) still has to come from me. AI can't tell you what your users actually need.
@kayaravenya Cheaper to build, yes. But easier? Not really β now the bottleneck isn't code, it's judgment. Knowing what to build, when to ship, what to ignore. AI removed the technical barrier and replaced it with a decision-making one.